PFE compared with MRNA: revenue, margins and what each company keeps, and the suppliers and customers both name

PFEPfizer Inc

Mkt capRevenueRevenue

MRNAModerna, Inc.

Mkt capRevenueRevenue

Compare

PFEPfizer Inc

MRNAModerna, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PFE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▼−2.18%×0.59

Q2 FY26±3.3%▲+1.52%×0.45

Q1 FY26±3.5%▲+0.57%×0.17

Feb 3 '26±3.2%▼−3.34%×1.03

MRNA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.0%▲+5.27%×0.76

Q2 FY26±9.8%▼−5.35%×0.54

= impliedPFE realized, solidMRNA realized, hatchedOne scale, both sides: full bar = 10%× = |realized| ÷ impliedSource: market data

Q1 FY26

±6.9%

▼−1.24%

×0.17

Feb 13 '26±7.7%▲+5.29%×0.69

PFEPfizer Inc

29.230.00%

Mkt cap$166.6BRevenue$16.6BQ3 FY26Revenue$62.6BFY25

MRNAModerna, Inc.

255.75▼−4.92%

Regular sessionNov 10 '26

Mkt cap$108.8BRevenue$1.3BQ3 FY26Revenue$1.9BFY25

Compare

Regular sessionNov 10 '26

PFEPfizer Inc

MRNAModerna, Inc.

29.230.00%

Price

255.75▼−4.92%

$166.6B

Mkt cap

$108.8B

Q3 FY26$16.6B

Revenue

$1.3BQ3 FY26

FY25$62.6B

Revenue

$1.9BFY25

PFE29.230.00%vsMRNA255.75▼−4.92%Regular sessionNov 10 '26